Market Exclusive

Analyst Activity – Sanford C. Bernstein Initiates Coverage On Ultragenyx Pharmaceutical (NASDAQ:RARE) With a Market Perform

Analyst Ratings For Ultragenyx Pharmaceutical (NASDAQ:RARE)

Today, Sanford C. Bernstein initiated coverage on Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Market Perform.

There are 1 sell rating, 6 hold ratings, 8 buy ratings on the stock.

The current consensus rating on Ultragenyx Pharmaceutical (NASDAQ:RARE) is Hold (Score: 2.47) with a consensus target price of $87.00 per share, a potential 22.83% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For Ultragenyx Pharmaceutical (NASDAQ:RARE)
Ultragenyx Pharmaceutical (NASDAQ:RARE) has insider ownership of 9.20% and institutional ownership of 95.32%.

Recent Trading Activity for Ultragenyx Pharmaceutical (NASDAQ:RARE)
Shares of Ultragenyx Pharmaceutical closed the previous trading session at 71.77 up +0.94 1.33% with 197,927 shares trading hands.

Exit mobile version